Health‑Economic Analyses of Diagnostics: Guidance on Design and Reporting, Pharmaco Economics. Read here

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model, Health Economics Review. Read here

Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries, British Medical Journal. Read here

Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review, Springer Nature. Read here

Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis, Clinical Microbiology and Infection. Read here

Multi-Criteria Decision Analysis to prioritise hospital admission of patients affected by COVID-19 in settings with hospital-bed shortage, ScienceDirect. Read here

Overview of AMR-related resources and services, public report. Read here

Analysing Microbiology In Vitro Diagnostics data using the OMOP DCM and SNOMED CT Encoding, presented at SNOMED Expo 2020. Read here

Health-Economics Modelling of Infectious Disease Diagnostics: current approaches and future opportunities, presented at ISPOR Europe 2019 in Copenhagen. Read here

HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI – An international overview of policies (Task 5.5). Read here

Interoperable Networks for AMR Laboratory Data – An overarching review of Task 3.4 and federated networking. Read here

OHDSI-OMOP – A proposed standard for AMR data Modelling: Readiness and Recommendations (Task 3.4). Read here

POC 1 Infrastructure documentation (Task 3.4). Read here